Journal
ENVIRONMENTAL TOXICOLOGY
Volume 36, Issue 5, Pages 773-781Publisher
WILEY
DOI: 10.1002/tox.23079
Keywords
butein; osteosarcoma; p53; ROS; senescence
Categories
Funding
- Changhua Christian Hospital Research Foundation, Changhua City, Taiwan [109-CCH-IRP-066]
Ask authors/readers for more resources
The flavonoid butein demonstrates anti-proliferative effects in human osteosarcoma cells by activating the tumor suppressor p53 and inducing senescence. Additionally, exposure to butein increases reactive oxygen species levels in the cells, leading to enhanced p53 activation and anti-proliferative effects. This suggests that butein is a promising candidate for cancer therapy against osteosarcoma.
Butein is a flavonoid isolated from various medicinal plants. It is known to have different biological activities including anti-inflammation, anti-adipogenesis, and anti-angiogenesis. In the study, we demonstrated the anti-proliferative effect of butein in human osteosarcoma U-2 OS cells. Our data showed that butein significantly suppressed the viability and colony formation ability of U-2 OS cells. Further experiments revealed butein exposure resulted in a cell cycle arrest at S and G2/M phase in U-2 OS cells. Importantly, we found that butein activated the tumor suppressor p53, and trigged a p53-dependent senescence in U-2 OS cells. Knockdown of p53 suppressed the senescence and rescued the viability in butein-treated U-2 OS cells. Furthermore, we observed that butein exposure significantly enhanced reactive oxygen species (ROS) levels in U-2 OS cells. Co-administration of the ROS inhibitor NAC largely abolished the up-regulated p53 protein level, and rescued the suppressed viability and colony formation ability in butein-exposed U-2 OS cells. Taken together, our data proposed the increased ROS by butein exposure activated p53, and the activated p53 was involved in the anti-proliferative effect of butein via inducing senescence in U-2 OS cells. This report suggests that butein is a promising candidate for cancer therapy against osteosarcoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available